AstraZeneca plc Sweden

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company headquartered in Cambridge, UK. Established in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group plc, AstraZeneca specializes in the research, development, and manufacturing of prescription medicines. Its diverse portfolio addresses major diseases across oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. The company operates globally, with a workforce of approximately 89,900 employees as of 2025. In 2025, AstraZeneca reported revenues of US$58.739 billion, reflecting its strong market position. The company's mission is to push the boundaries of science to deliver life-changing medicines, emphasizing innovation, sustainability, and patient-centricity. AstraZeneca's global presence and commitment to research and development have solidified its role as a leader in the pharmaceutical industry.